Loading organizations...
Loading organizations...
Hematopoietic stem cell expansion and gene therapy development.
Celaid Therapeutics has raised $11.3M across 2 funding rounds.
Celaid Therapeutics has raised $11.3M in total across 2 funding rounds.
Celaid Therapeutics has raised $11.3M in total across 2 funding rounds.
Celaid Therapeutics's investors include Japanese Agency for Medical Research and Development, Joyo Capital Partners, Osaka University Venture Capital, TechnoScience, Atsushi Usami, NEDO, SBI Investment.
Celaid Therapeutics has raised $11.3M across 2 funding rounds. Most recently, it raised $7.0M Series B in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 7, 2025 | $7.0M Series B | Japanese Agency for Medical Research and Development, Joyo Capital Partners, Osaka University Venture Capital, TechnoScience, Atsushi Usami | |
| May 8, 2024 | $4.3M Grant / Series A Extension | Joyo Capital Partners, NEDO, Osaka University Venture Capital, SBI Investment, TechnoScience, Atsushi Usami |